Key result
hiPSC cardiomyocyte patches improve post-MI recovery and elasticity via TGF-β1-mediated collagen remodeling.
Why the study?
Pluripotent stem cell-derived cardiomyocyte transplantation therapies are promising for myocardial infarction, but their molecular mechanisms remain elusive.
Does transplantation of a hiPSC-derived cardiomyocyte patch improve cardiac functional recovery and extracellular matrix remodeling in a rat model of myocardial infarction?
Does transplantation of a hiPSC-derived cardiomyocyte patch improve cardiac functional recovery and extracellular matrix remodeling in a rat model of myocardial infarction?
p-value: p=<0.05
Transplantation of hiPSC-derived cardiomyocyte patches improves cardiac contractility and elasticity following myocardial infarction through TGF-β1 paracrine signaling, which selectively promotes collagen type I production by cardiac fibroblasts.
Preclinical only; leaves open whether hiPSC-CM patch effects via TGF-β1 translate to human MI repair.
Myocardial infarction (MI) followed by chronic heart failure is the main cause of mortality of heart diseases. Although reparative cell transplantation therapies with pluripotent stem cell-derived cardiomyocytes (CMs) represent a promising therapeutic strategy, molecular mechanisms of the therapy remain elusive. Here, we show that transplantation of the human induced pluripotent stem cell (hiPSC)-derived CM patch onto the damaged heart after MI increases the ratio of collagen type I against collagen type III to modulate alignment of the collagen fibers at the infarcted zone. As a result, tissue elasticity of the heart is improved, and fibrosis at the remote zone is reduced. Mechanistically, we find that hiPSC-derived CM patches secrete TGF-β1, directly inducing collagen type I production in fibroblasts but not collagen type III. Our results suggest the direct effect of the transplanted CM patch on the cardiac fibroblasts to improve elasticity of the damaged heart, resulting in functional recovery after MI.
No takes yet. Share an insight, caveat, or question.
Torigata et al. (2026) studied Myocardial Infarction. Human iPSC-derived cardiomyocyte patch vs. Untransplanted control (MI without patch) was evaluated on Cardiac functional recovery (LV fractional shortening, LVEDP) and collagen type I to type III ratio (p=<0.05). Transplantation of human iPSC-derived cardiomyocyte patches onto the infarcted heart improved functional recovery and tissue elasticity by secreting TGF-β1, which increased the ratio of collagen type I to type III.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: